Integrin α(v)β3 promotes M21 melanoma growth in human skin by regulating tumor cell survival

Cancer Research

Volumn 59, Issue 11, 1999, Pages 2724-2730

  Petitclerc, Eric ^a   Strömblad, Staffan ^b   Von Schalscha, Tami L ^c   Mitjans, Francesc ^d   Piulats, Jaime ^d   Montgomery, Anthony M P ^c   Cheresh, David A ^c   Brooks, Peter C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d MERCK Farma Quim SA Barcelona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL INTERACTION; CELL SURVIVAL; GROWTH STIMULATION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; SKIN CARCINOGENESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DIVISION; CELL SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMANS; MELANOMA; MICE; MICE, SCID; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, VITRONECTIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; VITRONECTIN;

EID: 0344731256     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Koh, H. K. Cutaneous melanoma. N. Engl. J. Med., 325: 171-182, 1991.
2. Herlyn, M. Human melanoma: development and progression. Cancer Metastasis Rev., 9: 101-112, 1990.
3. Lu, C., and Kerbel, R. S. Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma. Curr. Opin. Oncol., 6: 212-220, 1991.
4. Rodeck, U., Melber, K., Kath, R., Mensson, H. D., Vorello, M., Alkinson, B., and Heslyn, M. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J. Investig. Dermatol., 97: 20-26, 1991.
5. 3 integrin and the 92-kDa gelalinase in human HT-144 melanoma cell tumors grown in nude mice. Int. J. Cancer, 68: 650-662, 1996.
6. Kramer, R. H., Vu, M., Cheng, Y-F., and Ramos, D. M. Integrin expression in malignant melanoma. Cancer Metastasis Rev., 10: 49-59, 1991.
7. Hynes, R. O. Integrins: versatility, modulation and signaling in cell adhesion. Cell, 69: 11-25, 1992.
8. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA, 91: 8856-8860, 1994.
9. Meredith, J. E., Fazeli, B., and Schwartz, M. A. The extracellular matrix as a survival factor. Mol. Biol. Cell, 4: 953-961, 1993.
10. 3 subunit with tumor progression. Cancer Res., 50: 6757-6764, 1990.
11. Cheresh, D. A., and Spiro, R. C. Biosynthetic and functional properties of Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen and von Willebrand factor. J. Biol. Chem., 262: 17703-17711, 1987.
12. v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. J. Cell Sci., 108: 2825-2838, 1995.
13. Funihata, K., Nugent, D. J., Bissonette, A., Aster, R. H., and Kunicki, T. J. On the association of platelet-specific alloantigen with glycoprotein IIIa: evidence for heterogeneity of glycoprotein IIIa. J. Clin. Investig., 80: 1624-1630, 1987.
14. Mujoo, K., Spiro, R. C., and Reisfeld, R. A. Characterization of a unique glycoprotein antigen expressed on the surface of human neuroblastoma cells. J. Biol. Chem., 261: 10299-10309, 1986.
15. 3 during angiogenesis. J. Clin. Investig., 98: 426-433, 1996.
16. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
17. Van, H-C., Jukasz, I., Dilewski, J., Murphy, G. F., Herlyn, M., and Albelda, S. M. Human/severe combined immunodeficient mouse chimeras. J. Clin. Investig., 91: 986-996, 1993.
18. Brooks, P. C., Silletti, S., von Schalscha, T. L., Friendlander, M., and Cheresh, D. A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell, 92: 391-400, 1998.
19. v gene expression in human melanoma tumorgenicity. J. Clin. Investig., 89: 2018-2022, 1992.
20. 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Investig., 96: 1815-1822, 1995.
21. Clark, W. H. J., Elder, D. E., and Van Horn, M. The biologic forms of malignant melanoma. Hum. Pathol., 17: 443-450, 1986.
22. Williams, G. T. Programmed cell death; apoptosis and oncogenesis. Cell, 65: 1097-1098, 1995.
23. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
24. Iron, V. A., Krajewski, S., Klein-Parker, H., Li, G., and Reed, J. C. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma. Am. J. Pathol., 146: 643-650, 1995.
25. Plettenberg, Ballaun, C., Pammer, J., Midner, M., Strunt, D., Weninger, W., and Tsckachler, E. Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture. Am. J. Pathol., 146: 651-659, 1995.
26. Oltvai, Z. N., Milliman, C. J., and Korsmeryer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
27. Jansen, B., Schlagbauer-Wadl, H., Brown, B. D., Bryon, R. N., Van Elsas, A., Muller, M., Wolff, K., Eichler, H. G., and Pehanberger, H. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat. Med., 4: 232-234, 1998.
28. Yin, C., Knudson, M., Korsmeyer, S. J., and Van Dyke, T. Bax suppresses tumori-genesis and stimulates apoptosis in vivo. Nature (Lond.), 385: 637-640, 1996.
29. 3 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA, 92: 6161-6165, 1995.
30. Herlyn, M., and Malkowicz, B. S. Regulatory pathways in tumor growth and invasion. Lab. Investig., 65: 262-271, 1991.
31. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
32. Dedhar, S. Integrin-mediated signal transduction in oncogenesis: an overview. Cancer Metastasis Rev., 14: 165-172, 1995.
33. 5 to promote tumor cell dissemination in vivo. J. Clin. Investig., 99: 1390-1398, 1997.
34. 5 mediates vitronectin-dependent adhesion of retinoic acid-differentiated neuroblastoma cells. Am. J. Pathol., 150: 1631-1646, 1997.
35. 3 integrin in human melanoma cell invasion. Proc. Natl. Acad. Sci. USA, 89: 1557-1561, 1992.
36. 3 binds to denatured collagen type I through RGD sites. Biochem. Biophys. Res. Commun., 182: 1025-1031, 1992.